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Background
The neutralizing antibody against HIV-1 is important for
the vaccine development. However, primary isolates of
HIV-1 have resistance to antibody neutralization. While a
neutralization epitope in V3 is exposed by conformational
change of gp120 following CD4-binding, anti-V3 IgG
molecules are too large to access V3-epitope. The purpose
of our study is to develop Fab and scFv fragments from
the anti-V3 monoclonal neutralizing antibody 5G2 for effi-
cient access to V3-epitope.
Methods
RNA was extracted from clonal cells producing 5G2,
and cDNA was prepared by reverse transcription. Using
primers for variable region of heavy and light chains,
the antibody genes were amplified by PCR, and inserted
into pComb3X vector. Fab and scFv were produced in
the transformed E. coli by induction with isopropyl-b-
D-thiogalactoside, and purified by nickel chelate
chromatography.
Results
Binding of recombinant 5G2 Fab and scFv to V3 epitope
was shown by enzyme-linked immune-sorbent assay
against V3 peptide. The flow cytometry analysis using cells
expressing HIV-1 Env revealed the higher intensity by
smaller antibody fragment, suggesting the increased acces-
sibility of small fragment to V3 epitope. Neutralizing activ-
ity of these 5G2 fragments were observed against both
primary HIV-1JR-FLwt and neutralization-sensitive var-
iant, JR-FLL175P. In the case of JR-FLwt, scFv showed a
significant improvement of neutralization.
Conclusion
The use of smaller antibody fragments, such as scFv and
Fab, may be one strategy to overcome steric constraints
that confer neutralization resistance of primary isolates.
We are now evaluating an effect of small antibody frag-
ments on neutralization against various primary isolates.
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